MODEPHARMA LIMITED, E14 9XL : Companies House Number 06332969

Executive summary

MODEPHARMA LIMITED presents a mixed risk profile: the company is clearly solvent with a strong liquidity position and long operating history, but the significant volatility in net assets and the 25.8% decline in shareholders' funds in the latest year raise legitimate concerns about business stability. The micro-entity filing status severely limits transparency into trading performance, making it impossible to determine whether asset fluctuations stem from operational issues, dividend distributions, or other factors. Further due diligence is recommended, particularly regarding the composition of current assets, profitability trends, and related party transactions, before committing institutional capital.

Read the full AI analysis →

Shareholders' funds

£199,264

Balance sheet as at 2025-08-31

View full accounts →

Overview

Company type: Private Limited Company
Incorporated: 2007-08-03
Employees: 2 (2025 accounts)
Registered office: Suite 16 Beaufort Court Admirals Way South Quay, Docklands, London, E14 9XL
Postcode: E14 9XL
Capital: 100 GBP
Accounts category: Micro

Accounts

Last made up to: 2025-08-31
Next due by: 2027-05-31
Financial year end: 31 August

Confirmation statement

Last statement dated: 2026-07-31
Next due by: 2027-08-14

View filing history →

Nature of business (SIC)

82990 Other business support service activities not elsewhere classified

Officers 3 current · 3 resigned

MRS Rima UPPAL Director

Appointed 2016-02-15

MR Oliver GUPTA Director

Appointed 2007-08-03

Rima UPPAL Secretary

Appointed 2007-08-03

View all officers and resignations →

Public contracts won 5

£1,166,142 total awarded value where published.

The Supply of Doxycycline & Placebo for the AFLOAT Trial

UNIVERSITY OF SOUTHAMPTON 2024-03-06 £64,590
Supply and Installation of Wet Lab Equipment to the University of Birmingham Dubai Campus

THE UNIVERSITY OF BIRMINGHAM 2023-08-02 £33,679
CAPE Trial Campaign 2 Investigational Medicinal Product Manufacturing

THE UNIVERSITY OF BIRMINGHAM 2023-03-31 £48,535
Contract for the Provision of Clinical Trials Services to the LOCI Trial Manufacture (package, label) and Distribute Investigational Medical Product (IMP) including Placebo to the University of Birmingham (Campaign 3)

THE UNIVERSITY OF BIRMINGHAM 2022-05-06 £84,704
Provision of Spironolactone and Placebo for Medical Trials

UNIVERSITY OF SOUTHAMPTON 2018-07-30 £934,634

Contains public sector information licensed under the Open Government Licence v3.0 (Contracts Finder).

Contact details

Website: modepharma.net

Previous company names

Name	Date changed
MODE BPO LIMITED	2015-03-06

Previous registered addresses 4

Address	Changed on
GISTERED OFFICE CHANGED ON 06/08/2009 FROM, SUITE 16 BEAUFORT COURT ADMIRALS WAY, SOUTH QUAY DOCKLANDS, LONDON, E14 9XL	2009-08-06
SUITE 16 BEAUFORT COURT ADMIRALS WAY, SOUTH QUAY DOCKLANDS, LONDON, E14 9XL	2009-08-06
16 BEAUFORT COURT, ADMIRALS WAY DOCKLANDS, LONDON, E14 9XL	2008-08-05
GISTERED OFFICE CHANGED ON 05/08/2008 FROM, 16 BEAUFORT COURT, ADMIRALS WAY DOCKLANDS, LONDON, E14 9XL	2008-08-05

Among its peers

Top 25%

by shareholders' funds, of 3,016 similar companies in E

Among the oldest 25% of its local peers, trading since 2007.

1,348 companies are registered at this postcode →

Competitors London

1. CANARY WHARF GROUP PLC

£2,228,867,123
2. CANARY WHARF ESTATE LIMITED

£673,449,805
3. PANDOX PEAK LIMITED

£328,472,026
4. CANARY WHARF INVESTMENTS (TWO) LIMITED

£133,437,534
5. CANARY WHARF PROPERTIES (FC2) LIMITED

£122,957,257

This company ranks 435 among other business support service activities not elsewhere classified in London.

Full league table →

The class of 2007

17%

of the 28,895 companies in this sector incorporated in 2007 are still active today; 81% have since been dissolved.

A fact about the year, not a forecast for this company.